DEN BOSCH FRED VAN, a director at $VRNS, sold 6,000 shares of the company on 06-04-2025 for an estimated $300,000. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.4% of their shares of this class of stock. Following this trade, they now own 131,666 shares of this class of $VRNS stock.
$VRNS Insider Trading Activity
$VRNS insiders have traded $VRNS stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $VRNS stock by insiders over the last 6 months:
- DEN BOSCH FRED VAN sold 6,000 shares for an estimated $300,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VRNS Hedge Fund Activity
We have seen 165 institutional investors add shares of $VRNS stock to their portfolio, and 220 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GREENVALE CAPITAL LLP removed 1,400,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $62,202,000
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 1,391,617 shares (-60.8%) from their portfolio in Q1 2025, for an estimated $56,290,907
- UBS GROUP AG added 1,373,919 shares (+134.2%) to their portfolio in Q1 2025, for an estimated $55,575,023
- VOYA INVESTMENT MANAGEMENT LLC added 1,152,687 shares (+98.6%) to their portfolio in Q1 2025, for an estimated $46,626,189
- ASSENAGON ASSET MANAGEMENT S.A. removed 1,102,014 shares (-97.9%) from their portfolio in Q1 2025, for an estimated $44,576,466
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 1,084,651 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $43,874,132
- THRIVENT FINANCIAL FOR LUTHERANS removed 1,065,635 shares (-40.7%) from their portfolio in Q1 2025, for an estimated $43,104,935
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$VRNS Analyst Ratings
Wall Street analysts have issued reports on $VRNS in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 05/07/2025
- UBS issued a "Buy" rating on 05/07/2025
- Barclays issued a "Overweight" rating on 05/07/2025
- Morgan Stanley issued a "Overweight" rating on 04/16/2025
- Cantor Fitzgerald issued a "Overweight" rating on 01/08/2025
To track analyst ratings and price targets for $VRNS, check out Quiver Quantitative's $VRNS forecast page.
$VRNS Price Targets
Multiple analysts have issued price targets for $VRNS recently. We have seen 4 analysts offer price targets for $VRNS in the last 6 months, with a median target of $52.0.
Here are some recent targets:
- Saket Kalia from Barclays set a target price of $54.0 on 05/07/2025
- Keith Weiss from Morgan Stanley set a target price of $46.0 on 04/16/2025
- Joseph Gallo from Jefferies set a target price of $50.0 on 12/19/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
